Bellerophon Therapeutics (BLPH) Prices 5M Common IPO at $12/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech stocks weigh on Wall Street as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- U.S. EV market shows signs of bottoming out: Bernstein
Bellerophon Therapeutics (BLPH) IPO Opens 17% Lower
February 13, 2015 12:06 PM ESTToday's IPO for Bellerophon Therapeutics (NASDAQ: BLPH) opened for trading at $10 after pricing 5,000,000 shares of its common stock at a public offering price of $12.00 per share, below the expected $14-$16 range.
In addition, Bellerophon has granted the underwriters an option to purchase up... More
